Vasoplegic syndrome after off-pump coronary artery bypass surgery

被引:26
作者
Gomes, WJ
Erlichman, MR
Batista, ML
Knobel, M
Almeida, DR
Carvalho, AC
Catani, R
Buffolo, E
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Cardiovasc Surg Discipline, BR-04023900 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Sao Paulo Hosp, BR-04023900 Sao Paulo, Brazil
关键词
heart surgery; coronary artery bypass surgery; vasoplegia; systemic inflammatory response syndrome;
D O I
10.1016/S1010-7940(02)00734-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The vasoplegic syndrome (VS) has been implicated in life-threatening complications after open heart surgery, where the whole-body inflammatory reaction is attributed to the cardiopulmonary bypass (CPB). Off-pump coronary artery bypass grafting (OPCAB) has been recently achieving growing enthusiasm mainly due avoiding the side effects of CPB. However herein the occurrence of VS in OPCAB is reported. Methods: The vasoplegic syndrome usual findings occurring in the early postoperative period include severe hypotension, tachycardia, normal or elevated cardiac output and low systemic vascular resistance. Four patients underwent to OPCAB presented all the signs of VS intraoperatively or within the first 6 postoperative h. Results: The patients needed aggressive vasoactive drug support for hemodynamic stabilization and all of them developed complications. These patients also had tendency to require administration of blood and blood derivatives due to diffuse and oozing type bleeding. Mean intensive care unit stay of surviving patients was 70 h and mean period of postoperative hospitalization was 9 days. Tumor necrosis factor-ot blood levels in one patient were elevated postoperatively though no signs of infection were observed. One patient died. Conclusions: Although vasoplegic syndrome can complicate OPCAB surgery, the rationale for avoiding CPB remains valid considering the benefits provided by OPCAB. (C) 2002 Elsevier Science B.V. All fights reserved.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 26 条
[1]  
Andrade JCS, 1996, REV BRAS CIR CARDIOV, V11, P107
[2]   Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent [J].
Argenziano, M ;
Chen, JM ;
Choudhri, AF ;
Cullinane, S ;
Garfein, E ;
Weinberg, AD ;
Smith, CR ;
Rose, EA ;
Landry, DW ;
Oz, MC .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (06) :973-980
[3]   Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules [J].
Asimakopoulos, G ;
Taylor, KM .
ANNALS OF THORACIC SURGERY, 1998, 66 (06) :2135-2144
[5]   Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass [J].
Brasil, LA ;
Gomes, WJ ;
Salomao, R ;
Buffolo, E .
ANNALS OF THORACIC SURGERY, 1998, 66 (01) :56-59
[6]  
BUFFOLO E, 1995, ANN THORAC SURG, V60, P938
[7]   HORMONAL RESPONSES TO GRADED SURGICAL STRESS [J].
CHERNOW, B ;
ALEXANDER, HR ;
SMALLRIDGE, RC ;
THOMPSON, WR ;
COOK, D ;
BEARDSLEY, D ;
FINK, MP ;
LAKE, CR ;
FLETCHER, JR .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (07) :1273-1278
[8]  
Edmunds L H Jr, 1995, Adv Card Surg, V6, P131
[9]  
GOMES WJ, 1994, J THORAC CARDIOV SUR, V107, P942
[10]  
Gomes WJ, 1998, J CARDIOVASC SURG, V39, P619